Skip to main content
Premium Trial:

Request an Annual Quote

Hyseq and Kirin Brewery Collaborate on Gene Discovery Project


SUNNYVALE, Calif.--Hyseq and Japan's Kirin Brewery have announced a collaboration in which Hyseq will use its proprietary gene discovery platform to target novel genes involved in cell growth regulation from specific cell lines provided by Kirin. Kirin and Hyseq will together develop and market pharmaceutical products emanating from the collaboration, the companies said.

Under terms of the agreement, Kirin will pay Hyseq $3 million for the initial phase of the collaboration plus additional amounts for milestones relating to clinical development and commercialization in Kirin territories of pharmaceutical products resulting from the collaboration.

The two-year deal is exclusive to the discovery of genes from the proprietary cell lines provided by Kirin. Hyseq will also receive royalties from the sale of associated pharmaceutical products in Kirin territories.

Filed under

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.